Name: The Ki67 Marker in Salivary Gland Tumors. (en Inglés)
SKU: 58142544
Price: 55950.00 CLP
Availability: InStock
Author: Garcia, Pedro Emilio ; Samar, María Elena ; Avila, Rodolfo Esteban
ISBN: 9786204047638

portada The Ki67 Marker in Salivary Gland Tumors. (en Inglés)

The Ki67 Marker in Salivary Gland Tumors. (en Inglés)

Formato

Libro Físico

Autor

Pedro Emilio Garcia

María Elena Samar

Rodolfo Esteban Avila

Editorial

Our Knowledge Publishing

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.2x0.4 cm

Peso

0.10 kg.

ISBN13

9786204047638

Categorías

Medicina: cuestiones generales

The Ki67 Marker in Salivary Gland Tumors. (en Inglés)

Pedro Emilio Garcia (Autor) · María Elena Samar (Autor) · Rodolfo Esteban Avila (Autor) · Our Knowledge Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 20 a 24 días háb.

$ 101.730$ 55.950

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 55.950

Llega entre el 14 Oct y el 20 Oct a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "The Ki67 Marker in Salivary Gland Tumors. (en Inglés)"

Salivary gland tumors are an infrequent and heterogeneous group of neoplasms, which implies difficulties in both diagnosis and prognosis of this pathology. Ki67 is a marker that is expressed in dividing cells and has been found to be associated with increased aggressiveness in different types of tumors. The aim of this work was to demonstrate the importance of Ki67 as a prognostic factor in patients with salivary gland tumors treated with radiotherapy.Patients with localized salivary gland tumors treated with radiotherapy were evaluated; Ki67 labeling was performed by immunohistochemistry; it was stratified into high (greater than 20%), low (between 1% and 20%) and negative (less than or equal to 1%); and the expression was related to the percentage of recurrences, distant metastases and deaths due to disease.Overall survival, recurrence-free survival, metastasis-free survival and cause-specific survival were calculated. In conclusion, high Ki67 expression was associated with a higher number of metastases and deaths from disease, with worse survival in patients with salivary gland tumors.